Investoren
Abalis Pharma AG
Abalis Pharma AG is active in the development, marketing and licensing of value added pharmaceutical products. The focus is on novel patentable solutions for solid dosage forms based on patent expired API's aimed at more patient compliance and safety. Abalis Pharma AG offers attractive marketing opportunities to the pharmaceutical industry.
It is located in Switzerland, in the proximity to health care and life science experts, research institutes and universities as well as the international pharmaceutical industry itself. www.abalis.ch
BioMedPartners
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The firm target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology. www.biomedpartners.ch
BayBG
Through its investments, BayBG is strengthening the capital base of 550 medium-sized businesses and manages currently more than EUR 300 Mio. The BayBG is thus the Bavarian market leader among medium-sized enterprise-oriented investment companies. Through its commitment, the BayBG enables the companies to realize expansion and innovation plans, make corporate succession plans as well as optimize the capital structure and implement turn-around measures. www.baybg.de
Venture Incubator AG
VI Partners is a Swiss venture capital firm that supports university spin-off's as well as other promising start-up companies with capital, coaching, consulting and networks. Via our current "Venture Incubator" fund VI Partners invests "Smart Money" to develop promising technology-based ideas for products and services into successful businesses. Venture Incubator was established by McKinsey & Company and the Swiss Federal Institute of Technology in Zürich (ETHZ), and started operations in 2001. It now manages an investment fund of CHF 101 million. Our investors represent 10 blue-chip enterprises from industry and finance. www.vipartners.ch
Vesalius Biocapital Partners
Vesalius Biocapital Partners manages two venture capital funds that invest in early- and mid-stage European life science companies creating innovative drugs, diagnostics, medical technologies and novel food applications
www.vesaliusbiocapital.com